J. Mark Ansermino
Observed names: , J Mark Ansermino, Ansermino, Ansermino Ansermino, Ansermino JM, Ansermino, J Mark, Ansermino, J. Mark, Ansermino, John Mark, Ansermino, Mark, Ansermino, Mark J, J M Ansermino, J MARK ANSERMINO, J Mark Ansermino, J. Ansermino, J. M. ANSERMINO, J. M. Ansermino, J. MARK ANSERMINO, J.M. ANSERMINO, J.M. Ansermino, J.MARK ANSERMINO, JMark Ansermino, John Ansermino, John M. Ansermino, John Mark Ansermino, M Ansermino, M. Ansermino, MARK ANSERMINO, Mark A. Ansermino, Mark Ansermino, Mark Ansermino, J., Mark J Ansermino, Mark J Ansermino, MBBCH MMed MSc, Mark J. Ansermino, U.O. Ansermino
Observed institutions: Northwestern University, Aga Khan University, University of British Columbia Hospital, Lurie Children's Hospital, Program for Appropriate Technology in Health, Children's National, University of British Columbia, Provincial Health Services Authority, Queen Mary University of London, King's College London, University of California, Irvine, Vancouver Hospital and Health Sciences Centre, Johannesburg Hospital, Churchill Hospital, Broomfield Hospital, John Radcliffe Hospital, Vancouver General Hospital, University of Alberta Hospital, University of Oxford, Lancet Laboratories, GlaxoSmithKline (United States), Children's & Women's Health Centre of British Columbia, Children's Hospital of Pittsburgh, International Federation of Gynaecology and Obstetrics, Women's Health Research Institute, BC Children's Hospital, Cochrane, Child and Family Research Institute, B.C. Women's Hospital & Health Centre, BC Children's Hospital Research Institute, University College London, Columbia University, Algoma University, Amsterdam UMC Location Vrije Universiteit Amsterdam, The University of Texas Health Science Center at Houston
ORCID: 0000-0001-8427-2035
Observed ORCID: 0000-0001-8427-2035
OpenAlex ID: A5010534406